Prior intraperitoneal injection of rat recombinant IL-6 increases hypothalamic IL-6 contents in subsequent forced swim stressor in rats

Neuropsychobiology

Volumn 54, Issue 3, 2007, Pages 186-194

  Matsumoto, Takuya ^a   Komori, Teruhisa ^a   Yamamoto, Masato ^b   Shimada, Yasuhito ^a   Nakagawa, Masanori ^a   Shiroyama, Takashi ^a   Inui, Koji ^c   Okazaki, Yuji ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Suzuka Kosei Hospital   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Forced swim test; Hypothalamus; Interleukin 6

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT INTERLEUKIN 6; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CLIMBING; COMPARATIVE STUDY; CONTROLLED STUDY; FORCED SWIMMING TEST; GENE EXPRESSION; HYPOTHALAMUS; IMMOBILIZATION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SWIMMING;

ANIMALS; HYPOTHALAMUS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; MALE; MESENCEPHALON; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 33847759878     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099946     Document Type: Article

References (71)

1. Capuron L, Dantzer R: Cytokines and depression: the need for a new paradigm. Brain Behav Immun 2003;17(suppl 1):S119-S124.
2. Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB: Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252-1257.
3. Maes M, Meltzer HY, Scharpe S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P: Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res 1993;49:151-165.
4. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995;34:301-309.
5. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K: Indicators of immune activation in major depression. Psychiatry Res 1996;64:161-167.
6. Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M: Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 1997;247:228-233.
7. Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M: The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 1998;49:211-219.
8. Leu SJ, Shiah IS, Yatham LN, Cheu YM, Lam RW: Immune-inflammatory markers in patients with seasonal affective disorder: effects of light therapy. J Affect Disord 2001;63:27-34.
9. Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E: Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999;45:833-839.
10. Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E: The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 2001;63:85-92.
11. Maier SF, Watkins LR: Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 1995;695:279-282.
12. Sakic B, Szechtman H, Braciak T, Richards C, Gauldie J, Denburg JA: Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull 1997;44:155-165.
13. Anisman H, Kokkinidis L, Borowski T, Merali Z: Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Res 1998;779:177-187.
14. Dantzer R, Bluthe RM, Laye S, Bret-Dibat JL, Parnet P, Kelley KW: Cytokines and sickness behavior. Ann N Y Acad Sci 1998;840:586-590.
15. Linthorst AC, Reul JM: Brain neurotransmission during peripheral inflammation. Ann N Y Acad Sci 1998;840:139-152.
16. Schobitz B, Pezeshki G, Pohl T, Hemmann U, Heinrich PC, Holsboer F, Reul JM: Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J 1995;9:659-664.
17. Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF: Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci 1998;18:2239-2246.
18. Deak T, Meriwether JL, Fleshner M, Spencer RL, Abouhamze A, Moldawer LL, Grahn RE, Watkins LR, Maier SF: Evidence that brief stress may induce the acute phase response in rats. Am J Physiol 1997;273:R1998-R2004.
19. LeMay LG, Vander AJ, Kluger MJ: The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 1990;47:957-961.
20. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS: Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993;133:2523-2530.
21. Butterweck V, Prinz S, Schwaninger M: The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice. Behav Brain Res 2003;144:49-56.
22. Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J: The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sci 1997;61:PL135-PL140.
23. Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J: The expressions of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sci 1998;62:2315-2320.
24. Johnson JD, O'Connor KA, Deak T, Stark M, Watkins LR, Maier SF: Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun 2002;16:461-476.
25. Johnson JD, O'Connor KA, Hansen MK, Watkins LR, Maier SF: Effects of prior stress on LPS-induced cytokine and sickness responses. Am J Physiol Regul Integr Comp Physiol 2003;284:R422-R432.
26. Johnson JD, O'Connor KA, Watkins LR, Maier SF: The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience 2004;127:569-577.
27. Tilders FJ, Schmidt ED: Cross-sensitization between immune and non-immune stressors. A role in the etiology of depression? Adv Exp Med Biol 1999;461:179-197.
28. Anisman H, Merali Z: Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003;35:2-11.
29. Glowinski J, Iversen LL: Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 1966;13:655-669.
30. Detke MJ, Wieland S, Lucki I: Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology (Berl) 1995;119:47-54.
31. Porsolt RD, Le Pichon M, Jalfre M: Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730-732.
32. Zhou D, Shanks N, Riechman SE, Liang R, Kusnecov AW, Rabin BS: Interleukin 6 modulates interleukin-1-and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology 1996;63:227-236.
33. Matta SG, Weatherbee J, Sharp BM: A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1 beta. Neuroendocrinology 1992;56:516-525.
34. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
35. Copland JA, Luxon BA, Ajani L, Maity T, Campagnaro E, Guo H, LeGrand SN, Tamboli P, Wood CG: Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene 2003;22:8053-8062.
36. del Cerro S, Borrell J: Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF. Brain Res 1990;528:162-164.
37. Yamada K, Iida R, Miyamoto Y, Saito K, Sekikawa K, Seishima M, Nabeshima T: Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. J Neuroimmunol 2000;111:131-138.
38. Pechnick RN, Chesnokova VM, Kariagina A, Price S, Bresee CJ, Poland RE: Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene. Neuropsychopharmacology 2004;29:770-776.
39. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H: An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998;84:923-933.
40. Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM: Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res 1998;811:111-121.
41. Lenczowski MJ, Bluthe RM, Roth J, Rees GS, Rushforth DA, van Dam AM, Tilders FJ, Dantzer R, Rothwell NJ, Luheshi GN: Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol 1999;276:R652-R658.
42. Bluthe RM, Michaud B, Poli V, Dantzer R: Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav 2000;70:367-373.
43. Deak T, Bellamy C, D'Agostino LG: Exposure to forced swim stress does not alter central production of IL-1. Brain Res 2003;972:53-63.
44. Maier SF, Nguyen KT, Deak T, Milligan ED, Watkins LR: Stress, learned helplessness, and brain interleukin-1 beta. Adv Exp Med Biol 1999;461:235-249.
45. Shintani F, Nakaki T, Kanba S, Sato K, Yagi G, Shiozawa M, Aiso S, Kato R, Asai M: Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci 1995;15:1961-1970.
46. Ishikawa I, Kitamura H, Kimura K, Saito M: Brain interleukin-1 is involved in blood interleukin-6 response to immobilization stress in rats. Jpn J Vet Res 2001;49:19-25.
47. Blanque R, Meakin C, Millet S, Gardner CR: Selective enhancement of LPS-induced serum TNF-alpha production by carrageenan pretreatment in mice. Gen Pharmacol 1998;31:301-306.
48. Schmidt ED, Janszen AW, Wouterlood FG, Tilders FJ: Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)-neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J Neurosci 1995;15:7417-7426.
49. Merali Z, Lacosta S, Anisman H: Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res 1997;761:225-235.
50. Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H: Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J Neurosci 1999;19:5654-5665.
51. Tilders FJ, Schmidt ED: Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness. Ann N Y Acad Sci 1998;840:65-73.
52. Ward LD, Howlett GJ, Discolo G, Yasukawa K, Hammacher A, Moritz RL, Simpson RJ: High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem 1994;269:23286-23289.
53. Vallieres L, Rivest S: Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 1999;140:3890-3903.
54. Miyahara S, Komori T, Fujiwara R, Shizuya K, Yamamoto M, Ohmori M, Okazaki Y: Effects of repeated stress on expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat hypothalamus and midbrain. Life Sci 2000;66:PL93-PL98.
55. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A: On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol 1989;19:689-694.
56. Gruol DL, Nelson TE: Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997;15:307-339.
57. Nelson TE, Campbell IL, Gruol DL: Altered physiology of Purkinje neurons in cerebellar slices from transgenic mice with chronic central nervous system expression of interleukin-6. Neuroscience 1999;89:127-136.
58. Van Wagoner NJ, Benveniste EN: Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 1999;100:124-139.
59. Isshiki H, Akira S, Tanabe O, Nakajima T, Shimamoto T, Hirano T, Kishimoto T: Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol 1990;10:2757-2764.
60. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K: Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 1990;10:561-568.
61. Zhang YH, Lin JX, Vilcek J: Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol 1990;10:3818-3823.
62. Merola M, Blanchard B, Tovey MG: The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity. J Interferon Cytokine Res 1996;16:783-798.
63. Miyazawa K, Mori A, Yamamoto K, Okudaira H: Transcriptional roles of CCAAT/enhancer binding protein-beta, nuclear factor-kappaB, and C-promoter binding factor 1 in interleukin (IL)-1beta-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J Biol Chem 1998;273:7620-7627.
64. Akira S, Isshiki H, Nakajima T, Kinoshita S, Nishio Y, Natsuka S, Kishimoto T: Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6. Ciba Found Symp 1992;167:47-62; discussion 62-47.
65. Hu HM, Baer M, Williams SC, Johnson PF, Schwartz RC: Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J Immunol 1998;160:2334-2342.
66. Kordula T, Rydel RE, Brigham EF, Horn F, Heinrich PC, Travis J: Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem 1998;273:4112-4118.
67. Marz P, Cheng JG, Gadient RA, Patterson PH, Stoyan T, Otten U, Rose-John S: Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 1998;95:3251-3256.
68. Marz P, Herget T, Lang E, Otten U, Rose-John S: Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur J Neurosci 1997;9:2765-2773.
69. Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN: Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol 1998;161:4992-4999.
70. Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN: Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 1999;19:5236-5244.
71. Sparacio SM, Zhang Y, Vilcek J, Benveniste EN: Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J Neuroimmunol 1992;39:231-242.